Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI

被引:16
|
作者
Chen, Guo-xiong [1 ]
Wang, Hong-na [1 ]
Zou, Jin-lin [1 ]
Yuan, Xiao-xu [1 ]
机构
[1] Zhoushan Hosp Zhejiang Prov, Dept Cardiol, Zhoushan 316000, Peoples R China
关键词
Acute ST-elevation myocardial infarction; Elderly; Emergency coronary intervention; Nicorandil; Tirofiban; Myocardial reperfusion; PERCUTANEOUS CORONARY INTERVENTION; NO-REFLOW; OUTCOMES; COMBINATION; INHIBITORS; CARE;
D O I
10.5847/wjem.j.1920-8642.2020.03.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: This study investigated the effects of the intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction (STEMI) after emergency percutaneous coronary intervention (PCI). METHODS: Seventy-eight STEMI patients with age >65 years who underwent emergency PCI were consecutively enrolled. These patients received conventional PCI and were randomly divided into a control group and a treatment group (n=39 per group). The control group received an intracoronary injection of tirofiban followed by a maintenance infusion for 36 hours after surgery. The treatment group received intracoronary injection of tirofiban and nicorandil, and then intravenous infusion of tirofiban and nicorandil 36 hours after surgery. The following parameters were measured: TIMI grade, corrected TIMI frame count (cTFC), TIMI myocardial perfusion grade (TMPG), ST-segment resolution (STR) rate 2 hours post-operatively, resolution of ST-segment elevation (STR) at 2 hours postoperatively, peak level of serum CK-MB, left ventricular end diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) at 7-10 days postoperatively, and major adverse cardiac events (MACEs) in-hospital and within 30 days post-operatively. RESULTS: Compared with the control group, more patients in the treatment group had TIMI 3 and TMPG 3, and STR after PCI was significantly higher. The treatment group also had significantly lower cTFC, lower infarction relative artery (IRA), lower peak CK-MB, and no reflow ratio after PCI. The treatment group had significantly higher LVEDD and LVEF but lower incidence of MACEs than the control group. CONCLUSION: The intracoronary injection of nicorandil combined with tirofiban can effectively improve myocardial reperfusion in elderly STEMI patients after emergency PCI and improve short-term prognoses.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [31] Prognosis of patients with cardiogenic shock following acute myocardial infarction: The difference between ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction
    Tsai, Ming-Lung
    Hsieh, Ming-Jer
    Chen, Chun-Chi
    Wu, Victor Chien-Chia
    Lan, Wen-Ching
    Huang, Yu-Tung
    Hsieh, I-Chang
    Chang, Shang-Hung
    MEDICINE, 2022, 101 (36) : E30426
  • [32] Short-term prognosis of ST elevation myocardial infarction in patients with hypertension
    Salwa, Pawel
    Gorczyca-Michta, Iwona
    Wozakowska-Kaplon, Beata
    ARTERIAL HYPERTENSION, 2012, 16 (03): : 134 - 140
  • [33] Assessment of postoperative prognosis in patients with acute ST-segment elevation myocardial infarction after PCI using LRP1
    Guan, Jingwen
    Xu, Yikang
    Liu, Limin
    Su, Mengran
    Ma, Jingru
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2025, 12
  • [34] High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction
    Desmet, Walter
    Bogaert, Jan
    Dubois, Christophe
    Sinnaeve, Peter
    Adriaenssens, Tom
    Pappas, Christos
    Ganame, Javier
    Dymarkowski, Steven
    Janssens, Stefan
    Belmans, Ann
    Van de Werf, Frans
    EUROPEAN HEART JOURNAL, 2011, 32 (07) : 867 - 877
  • [35] The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients
    Vatan, Mehmet Bulent
    Cakmak, Ahmet Can
    Agac, Suret
    Eynel, Emre
    Erkan, Hakan
    ANGIOLOGY, 2023, 74 (04) : 365 - 373
  • [36] Glycoprotein IIb/IIIa Inhibitor (Tirofiban) in Acute ST-Segment Elevation Myocardial Infarction
    Fang, Ching-Chang
    Jao, Yeun Tarl Fresner Ng
    Chen, Yi
    Yu, Ching-Lung
    Wang, Shih-Pu
    ANGIOLOGY, 2009, 60 (02) : 192 - 200
  • [37] Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
    De Luca, G
    Smit, JJ
    Ernst, N
    Suryapranata, H
    Ottervanger, JP
    Hoorntje, JCA
    Dambrink, JHE
    Gosslink, ATM
    Boer, MJC
    van't Hof, AWJ
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (05) : 820 - 823
  • [38] Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial
    Ohman, EM
    Van de Werf, F
    Antman, EM
    Califf, RM
    de Lemos, JA
    Gibson, CM
    Oliverio, RL
    Harrelson, L
    McCabe, C
    DiBattiste, P
    Braunwald, E
    AMERICAN HEART JOURNAL, 2005, 150 (01) : 79 - 88
  • [39] Impact of adjunctive Tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
    De Luca, G.
    van't Hof, A. W. J.
    Suryapranata, H.
    Ottervanger, J. P.
    Gosselink, M.
    Dambrink, J. H. E.
    Hoorntje, J. C. A.
    de Boer, M. J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 49 - 50
  • [40] Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI)
    Gao, Lu
    Cao, Zhenhua
    Zhang, Hong
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2699 - 2705